Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-02-2018 | Original Article

Sustained high serum caspase-3 concentrations and mortality in septic patients

Authors: L. Lorente, M. M. Martín, A. Pérez-Cejas, A. F. González-Rivero, R. O. López, J. Ferreres, J. Solé-Violán, L. Labarta, C. Díaz, S. Palmero, A. Jiménez

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2018

Abstract

Caspase-3 is the main executor of the apoptotic process. Higher serum caspase-3 concentrations in non-survivor compared to survivor septic patients have been found. The objectives of this work (with the increase of sample size to 308 patients, and the determination of serum caspase-3 concentrations also on days 4 and 8 of diagnosis of severe sepsis) were to know whether an association between serum caspase-3 concentrationss during the first week, degree of apoptosis, sepsis severity, and sepsis mortality exists. We collected serum samples of 308 patients with severe sepsis from eight intensive care units on days 1, 4 and 8 to measure concentrations of caspase-3 and caspase-cleaved cytokeratin (CCCK)-18 (to assess degree of apoptosis). End point was 30-day mortality. We found higher serum concentrations of caspase-3 and CCCK-18 in non-survivors compared to survivors on days 1 (p < 0.001), 4 (p < 0.001), and 8 (p < 0.001). We found an association between serum caspase-3 concentrations on days 1, 4 and 8 of severe sepsis diagnosis and serum CCCK-18 concentrations (p < 0.001), SOFA (p < 0.001), serum acid lactic concentrations (p < 0.001), and 30-day sepsis mortality (p < 0.001). The new findings of this work were that an association between serum caspase-3 concentrations during the first week, apoptosis degree, sepsis severity, and sepsis mortality exists.

Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D, Sepsis occurrence in acutely ill patients investigators (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–353

Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310CrossRefPubMed

Fischer U, Schulze-Osthoff K (2005) Apoptosis-based therapies and drug targets. Cell Death Differ 12:942–961CrossRefPubMed

Wesche-Soldato DE, Swan RZ, Chung CS, Ayala A (2007) The apoptotic pathway as a therapeutic target in sepsis. Curr Drug Targets 8:493–500CrossRefPubMedPubMedCentral

Huttunen R, Aittoniemi J (2011) New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis. J Inf Secur 63:407–419

Harjai M, Bogra J, Kohli M, Pant AB (2013) Is suppression of apoptosis a new therapeutic target in sepsis? Anaesth Intensive Care 41:175–183PubMed

Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, Xanthoudakis S, Roy S, Black C, Grimm E, Aspiotis R, Han Y, Nicholson DW, Karl IE (2000) Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 1:496–501CrossRefPubMed

Matsuda N, Teramae H, Futatsugi M, Takano K, Yamamoto S, Tomita K, Suzuki T, Yokoo H, Koike K, Hattori Y (2010) Up-regulation of histamine H4 receptors contributes to splenic apoptosis in septic mice: counteraction of the antiapoptotic action of nuclear factor-kappaB. J Pharmacol Exp Ther 332:730–737CrossRefPubMed

Li P, Bledsoe G, Yang ZR, Fan H, Chao L, Chao J (2014) Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis. Immunology 142:216–226CrossRefPubMedPubMedCentral

10.

Supinski GS, Callahan LA (2014) ß-hydroxy-ß-methylbutyrate (HMB) prevents sepsis-induced diaphragm dysfunction in mice. Respir Physiol Neurobiol 196:63–68CrossRefPubMedPubMedCentral

11.

Ali I, Nanchal R, Husnain F, Audi S, Konduri GG, Densmore JC, Medhora M, Jacobs ER (2013) Hypoxia preconditioning increases survival and decreases expression of toll-like receptor 4 in pulmonary artery endothelial cells exposed to lipopolysaccharide. Pulm Circ 3:578–588CrossRefPubMedPubMedCentral

12.

Stoyanoff TR, Todaro JS, Aguirre MV, Zimmermann MC, Brandan NC (2014) Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: involvement of mitochondria-regulated apoptosis. Toxicology 318:13–21CrossRefPubMed

13.

Inoue S, Sato T, Suzuki-Utsunomiya K, Komori Y, Hozumi K, Chiba T, Yahata T, Nakai K, Inokuchi S (2013) Sepsis-induced hypercytokinemia and lymphocyte apoptosis in aging-accelerated Klotho knockout mice. Shock 39:311–316CrossRefPubMed

14.

Xie K, Yu Y, Huang Y, Zheng L, Li J, Chen H, Han H, Hou L, Gong G, Wang G (2012) Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis. Shock 37:548–555PubMed

15.

Shinozaki S, Inoue Y, Yang W, Fukaya M, Carter EA, Yu YM, Fischman A, Tompkins R, Kaneki M (2010) Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice. Biochem Biophys Res Commun 391:1459–1464CrossRefPubMed

16.

Supinski GS, Wang W, Callahan LA (2009) Caspase and calpain activation both contribute to sepsis-induced diaphragmatic weakness. J Appl Physiol 107:1389–1396CrossRefPubMedPubMedCentral

17.

Matsuda N, Takano Y, Kageyama S, Hatakeyama N, Shakunaga K, Kitajima I, Yamazaki M, Hattori Y (2007) Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock. Cardiovasc Res 76:132–140CrossRefPubMed

18.

Ozdulger A, Cinel I, Koksel O, Cinel L, Avlan D, Unlu A, Okcu H, Dikmengil M, Oral U (2003) The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock 19:366–372CrossRefPubMed

19.

Zhang Y, Li J, Lou J, Zhou Y, Bo L, Zhu J, Zhu K, Wan X, Cai Z, Deng X (2011) Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit Care 15:R70CrossRefPubMedPubMedCentral

20.

Delogu G, Famularo G, Tellan G, Marandola M, Antonucci A, Signore M, Marcellini S, Moretti S (2008) Lymphocyte apoptosis, caspase activation and inflammatory response in septic shock. Infection 36:485–487CrossRefPubMed

21.

Weber SU, Schewe JC, Lehmann LE, Müller S, Book M, Klaschik S, Hoeft A, Stüber F (2008) Induction of Bim and bid gene expression during accelerated apoptosis in severe sepsis. Crit Care 12:R128CrossRefPubMedPubMedCentral

22.

Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27:1230–1251CrossRefPubMed

23.

Clementi A, Virzì GM, Brocca A, Pastori S, de Cal M, Marcante S, Granata A, Ronco C (2016) The role of cell-free plasma DNA in critically ill patients with sepsis. Blood Purif 41:34–40CrossRefPubMed

24.

Nguyen HB, Loomba M, Yang JJ, Jacobsen G, Shah K, Otero RM, Suarez A, Parekh H, Jaehne A, Rivers EP (2010) Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock. J Inflamm (Lond) 7:6CrossRef

25.

Lorente L, Martín MM, Ferreres J, Solé-Violán J, Labarta L, Díaz C, Jiménez A, Borreguero-León JM (2016) Serum caspase 3 levels are associated with early mortality in severe septic patients. J Crit Care 34:103–106CrossRefPubMed

26.

Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, International Sepsis Definitions Conference (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29:530–538CrossRefPubMed

27.

Lorente L, Martín MM, Pérez-Cejas A, López RO, Ferreres J, Solé-Violán J, Labarta L, Díaz C, Palmero S, Buitrago M, Jiménez A, Borreguero-León JM (2017) Higher serum caspase-cleaved cytokeratin-18 levels during the first week of sepsis diagnosis in non-survivor patients. Clin Chem Lab Med 55(10):1621–1629

28.

Lorente L, Martín MM, Abreu-González P, Domínguez-Rodriguez A, Labarta L, Díaz C, Solé-Violán J, Ferreres J, Cabrera J, Igeño JC, Jiménez A (2013) Sustained high serum malondialdehyde levels are associated with severity and mortality in septic patients. Crit Care 17:R290CrossRefPubMedPubMedCentral

29.

Lorente L, Martín MM, Solé-Violán J, Blanquer J, Labarta L, Díaz C, Borreguero-León JM, Orbe J, Rodríguez JA, Jiménez A, Páramo JA (2014) Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio. PLoS One 9:e94318CrossRefPubMedPubMedCentral

30.

Lorente L, Martín MM, López-Gallardo E, Blanquer J, Solé-Violán J, Labarta L, Díaz C, Jiménez A, Montoya J, Ruiz-Pesini E (2015) Decrease of oxidative phosphorylation system function in severe septic patients. J Crit Care 30:935–939CrossRefPubMed

31.

Lorente L, Martín MM, Pérez-Cejas A, Ferreres J, Solé-Violán J, Labarta L, Díaz C, Jiménez A (2017) Non-survivor septic patients have persistently higher serum sCD40L levels than survivors. J Crit Care 41:177–182CrossRefPubMed

32.

Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829CrossRefPubMed

33.

Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG, for the Working Group on Sepsis-related Problems of the European Society of Intensive Care Medicine (1996) The sepsis-related organ failure assessment (SOFA) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710CrossRefPubMed

34.

Roth GA, Krenn C, Brunner M, Moser B, Ploder M, Spittler A, Pelinka L, Sautner T, Wolner E, Boltz-Nitulescu G, Ankersmit HJ (2004) Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope m30 in critically ill patients. Shock 22:218–220CrossRefPubMed

35.

Moore DJ, Greystoke A, Butt F, Wurthner J, Growcott J, Hughes A, Dive C (2012) A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patients. Clin Drug Investig 32:179–187CrossRefPubMed

36.

Hofer S, Brenner T, Bopp C, Steppan J, Lichtenstern C, Weitz J, Bruckner T, Martin E, Hoffmann U, Weigand MA (2009) Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction. Crit Care 13:R93CrossRefPubMedPubMedCentral

37.

Chu PG, Weiss LM (2002) Keratin expression in human tissues and neoplasms. Histopathology 40:403–439CrossRefPubMed

38.

Caulín C, Salvesen GS, Oshima RG (1997) Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 138:1379–1394CrossRefPubMedPubMedCentral

Title: Sustained high serum caspase-3 concentrations and mortality in septic patients
Authors: L. Lorente
M. M. Martín
A. Pérez-Cejas
A. F. González-Rivero
R. O. López
J. Ferreres
J. Solé-Violán
L. Labarta
C. Díaz
S. Palmero
A. Jiménez
Publication date: 01-02-2018
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-017-3129-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2018

The pathogenesis of microcephaly resulting from congenital infections: why is my baby’s head so small?

Risk factors for pneumococcal endocarditis

Emergence and establishment of KPC-2-producing ST11 Klebsiella pneumoniae in a general hospital in Shanghai, China

Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis

A decision support model to predict the presence of an acute infiltrate on chest radiograph

Antibiotic prescription and clinical management of common infections among general practitioners in Latvia, Lithuania, and Sweden: a pilot survey with a simple protocol

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials